Inhibitory effect of tumor cell-derived lactic acid on human T cells.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Blood

• Publication date

  2007-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2006-07-035972PMID 17255361
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor-derived lactic acid modulates dendritic cell activation and antigen expression.

  2006cited by this paper
• Monocarboxylate transporter MCT1 is a target for immunosuppression

  2005cited by this paper
• Glucose Availability Regulates IFN-γ Production and p70S6 Kinase Activation in CD8+ Effector T Cells1

  2005cited by this paper
• Why do cancers have high aerobic glycolysis?

  2004cited by this paper
• Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology.

  2004cited by this paper
• Presence and Localization of Three Lactic Acid Transporters (MCT1, −2, and −4) in Separated Human Granulocytes, Lymphocytes, and Monocytes

  2004cited by this paper
• Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance.

  2004cited by this paper
• Regulation of T Lymphocyte Metabolism

  2004cited by this paper
• Novel polyamine coating providing non-covalent deactivation and reversed electroosmotic flow of fused-silica capillaries for capillary electrophoresis.

  2003cited by this paper
• Survival and Tumor Localization of Adoptively Transferred Melan-A-Specific T Cells in Melanoma Patients 1

  2003cited by this paper
• Hypoxia-inducible Factor 1 Activation by Aerobic Glycolysis Implicates the Warburg Effect in Carcinogenesis*

  2002cited by this paper
• Simultaneous determination of anionic intermediates for Bacillus subtilis metabolic pathways by capillary electrophoresis electrospray ionization mass spectrometry.

  2002cited by this paper
• An improved flow cytometric assay for the determination of cytotoxic T lymphocyte activity.

  2002cited by this paper
• Interleukin‐10 expressed at early tumour sites induces subsequent generation of CD4+ T‐regulatory cells and systemic collapse of antitumour immunity

  2001cited by this paper
• The effects of extracellular pH on immune function

  2001cited by this paper
• Activation of the HIF pathway in cancer.

  2001cited by this paper
• Post-transcriptional effects of extracellular pH on tumour necrosis factor-alpha production in RAW 246.7 and J774 A.1 cells.

  2001cited by this paper
• The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages

  2000cited by this paper
• High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers.

  2000cited by this paper
• Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing.

  2000cited by this paper
• Status of Activation of Circulating Vaccine-Elicited CD8+ T Cells

  2000cited by this paper
• The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages.

  2000cited by this paper
• An Expanded Peripheral T Cell Population to a Cytotoxic T Lymphocyte (Ctl)-Defined, Melanocyte-Specific Antigen in Metastatic Melanoma Patients Impacts on Generation of Peptide-Specific Ctls but Does Not Overcome Tumor Escape from Immune Surveillance in Metastatic Lesions

  1999cited by this paper
• Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

  1999cited by this paper
• The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation.

  1999cited by this paper
• Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression.

  1999cited by this paper
• Correlation of high lactate levels in head and neck tumors with incidence of metastasis.

  1997cited by this paper
• The clinical value of lactate dehydrogenase in serum: a quantitative review.

  1997cited by this paper
• V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression.

  1997cited by this paper
• Isoenzyme-specific regulation of genes involved in energy metabolism by hypoxia: similarities with the regulation of erythropoietin.

  1996cited by this paper
• Lactic acidosis and hypoglycemia in a patient with high-grade non-Hodgkin's lymphoma and elevated circulating TNF-α

  1996cited by this paper
• Direct evidence to support the immunosurveillance concept in a human regressive melanoma.

  1994cited by this paper
• Demonstration of organic anion transport in T lymphocytes. L-lactate and fluo-3 are target molecules.

  1994cited by this paper
• pH-dependent LAK cell cytotoxicity.

  1994cited by this paper
• Transport of lactate and other monocarboxylates across mammalian plasma membranes.

  1993cited by this paper
• Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma.

  1993cited by this paper
• Influence of tumour physico-chemical conditions on interleukin-2-stimulated lymphocyte proliferation.

  1992cited by this paper
• Comparative studies of the cytotoxic T lymphocyte-mediated cytotoxicity and of extracellular ATP-induced cell lysis. Different requirements in extracellular Mg2+ and pH.

  1991cited by this paper
• Regulation of glycolysis in the erythrocyte: role of the lactate/pyruvate and NAD/NADH ratios.

  1991cited by this paper
• The energy state of tumor-bearing rats.

  1991cited by this paper
• Cell and environment interactions in tumor microregions: the multicell spheroid model.

  1988cited by this paper
• Regulation of cytotoxic T-lymphocyte activation by L-lactate and pyruvate.

  1985cited by this paper
• Liquid-overlay culture of cellular spheroids.

  1984cited by this paper
• [On the facultative anaerobiosis of cancer cells and its use in chemotherapy].

  1961cited by this paper

• Immunometabolic editing of the tumor microenvironment: from reprogramming mechanisms to therapeutic vulnerabilities

  2026cites this paper
• T‐Cell Immunity and Lung Cancer

  2026cites this paper
• Multi-Omics Characterization of Lactate-Associated Molecular Subtypes in Lung Cancer Suggests a Role for DKK1 in Lactate-Linked Migration, Invasion, and Lactylation Programs

  2026cites this paper
• Lactic Acid in Tumour Biology

  2026cites this paper
• Metabolic reprogramming in colorectal cancer: Mechanisms and therapeutic insights

  2026cites this paper
• Immune Evasion in Pancreatic Ductal Adenocarcinoma: Mechanistic Insights and Emerging Strategies to Reinvigorate Anti-Cancer Immunity

  2026cites this paper
• Metabolic traits of T cells and the implications in autoimmune diseases.

  2026cites this paper
• Lactate metabolism and protein lactylation in cancer

  2026cites this paper
• Harnessing tumor acidity: innovative lactic acid-responsive promoter enables precision control of CAR-T cell activity in solid tumors.

  2026cites this paper
• GPR81 Activation by Lactate Delays Inflammation Resolution in Acute Lung Injury

  2026cites this paper
• CAR-T cell therapies are coming after glioblastoma: An overview of early phase clinical trials and future perspectives

  2026cites this paper
• MYC at the tumor–immune interface: mechanisms of immune escape and immunotherapy resistance

  2026cites this paper
• Tumor Cells as Architects of Immune Refractoriness: Dismantling Intrinsic Programs of Tumor Cells for Clinical Translation.

  2026cites this paper
• Extracellular CD44 lactylation impairs CD8+ T cell function in KRAS-mutant colorectal cancer.

  2026cites this paper
• Prominent protumoral cellular compartments of the tumor microenvironment in triple-negative breast cancer

  2026cites this paper
• GLUT1 expression, lymphocyte distribution and CD3+ T-cell metabolic subsets as predictive markers of response to immunotherapy in advanced melanoma

  2026cites this paper
• Metabolic Checkpoints in CD8+ T Cells within the Tumor Microenvironment: A Comprehensive Review and Emerging Insights

  2026cites this paper
• Laryngeal squamous cell carcinoma: a functional "two-hit" model of papillomavirus-Epstein-Barr virus synergistic carcinogenesis.

  2026cites this paper
• From Immunobiology to Clinical Application: Tumor-Infiltrating Lymphocytes in Melanoma

  2026cites this paper
• The signal hijacker: How tumors co-opt chemical, electrical, and mechanical cues to thrive.

  2026cites this paper
• Genetically engineered cellular membrane-camouflaged nanoparticles amplify immune response against recurrent metastatic triple-negative breast cancer.

  2026cites this paper
• Tumor microenvironment heterogeneity and immunotherapy resistance: multidimensional modulation strategies for precision breakthroughs

  2026cites this paper
• CRISPR/Cas strategies to enhance CAR T-cell function and persistence via metabolic reprogramming.

  2026cites this paper
• Revitalizing T cells: breakthroughs and challenges in overcoming T cell exhaustion

  2026cites this paper
• Role and Molecular Mechanisms of Aerobic Glycolysis in Gastrointestinal Tumors

  2026cites this paper
• GCN5-ERK lactylation-phosphorylation loop amplifies lactate-driven cancer progression.

  2026cites this paper
• Common gamma chain cytokines-driven optimization of chimeric antigen receptor T cells: Mechanistic insights and future directions

  2026cites this paper
• The Role of Lactic Acid Metabolism in Anti-tumor Immunity.

  2026cites this paper
• Molecular and cellular landscapes of the immune microenvironment and multiomic biomarker-sets in platinum-resistant recurrent ovarian cancers.

  2026cites this paper
• Recent advances in targeted and immunotherapeutic strategies for cholangiocarcinoma: A comprehensive review

  2026cites this paper
• Lactate: elucidating its indispensable role in human health

  2026cites this paper
• The Increased Secretion of Lactate Observed in Obesity and Aging Leads to the Generation of Pathogenic B Cells

  2026cites this paper
• Targeting glycolysis in prostate cancer: Molecular mechanisms and therapeutic advances.

  2026cites this paper
• Improvement of Tumor Hypoperfusion and Hypoxia via Low-intensity Ultrasound-stimulated Microbubbles Combined with Alprostadil.

  2026cites this paper
• The lactylation-immunosuppression network in cancer: driving a metabolic-epigenetic axis

  2026cites this paper
• Immunometabolism, an emerging field in perioperative and critical care medicine: a narrative review.

  2026cites this paper
• Dual role of lactate in human health and disease

  2025cites this paper
• TRIM65 as a key regulator of ferroptosis and glycolysis in lactate-driven renal tubular injury and diabetic kidney disease.

  2025cites this paper
• Scalable production process development for NK cells targeting large-scale expansion

  2025cites this paper
• Metabolic adaptations in cancer progression.

  2025cites this paper
• Comprehensive analysis of exosome-related gene signature in multiple myeloma prognosis and immune microenvironment evaluation

  2025cites this paper
• Role of monocarboxylate transporters in cancer immunology and their therapeutic potential

  2025cites this paper
• AFF4 promotes tumor progression and cisplatin resistance by modulating the PTEN/PI3K/AKT/mTOR axis to accelerate glycolysis in lung adenocarcinoma

  2025cites this paper
• A critical review of the synergistic potential of targeting p53 and CAR T cell therapy in cancer treatment.

  2025cites this paper
• Lactylation in Tumor Immune Escape and Immunotherapy: Multifaceted Functions and Therapeutic Strategies

  2025cites this paper
• The HIF axes in cancer: angiogenesis, metabolism, and immune-modulation.

  2025cites this paper
• Lactate metabolism reprogramming in PDAC: Potential for tumor therapy.

  2025cites this paper
• Role of Tumor Microenvironment in Prostate Cancer Immunometabolism

  2025cites this paper
• An oxygen-generating nanoplatform remodels the immunosuppressive tumor microenvironment via synergistic lactate depletion and sonodynamic therapy

  2025cites this paper
• Optimising and adapting perfusion feeds in serum-free medium to intensify CAR-T cell expansion in stirred-tank bioreactors

  2025cites this paper
• An ultrasound-visualized methionine partitioning nano-modulator for enhanced immunotherapy against anti-PD-1 resistant tumors

  2025cites this paper
• Unraveling the prognostic significance and molecular mechanisms of HKDC1 in cancer via integrated multi-omics and experimental validation.

  2025cites this paper
• Spatial heterogeneity in glioblastoma: Decoding the role of perfusion.

  2025cites this paper
• Metabolic reprogramming in melanoma therapy

  2025cites this paper
• Abnormal metabolic activation of CD8+ T cells correlates with poor prognosis in acute myeloid leukemia

  2025cites this paper
• pH-Sensitive TRPC5 Is Differentially Expressed in Various Common Skin Tumors

  2025cites this paper
• Clinical Applications and Resistance Challenges of PD-1/PD-L1 Inhibitors in Gastric Cancer

  2025cites this paper
• Mechanisms of T-cell metabolic reprogramming in the microenvironment of acute myeloid leukemia and its therapeutic potential (Review)

  2025cites this paper
• Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches

  2025cites this paper
• How lactate and lactylation shape the immunity system in atherosclerosis (Review)

  2025cites this paper
• Lactylation: A new direction for tumor-targeted therapy.

  2025cites this paper
• A bibliometric analysis of inflammation and thyroid carcinoma: research trends and future perspectives

  2025influential citation
• Metabolic reprogramming of drug resistance in pancreatic cancer: mechanisms and effects.

  2025cites this paper
• Nutrient-gene therapy as a strategy to enhance CAR T cell function and overcome barriers in the tumor microenvironment

  2025cites this paper
• The role of MCT1 in tumor progression and targeted therapy: a comprehensive review

  2025cites this paper
• Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies.

  2025cites this paper
• Lactylation in cancer biology: Unlocking new avenues for research and therapy

  2025cites this paper
• Optimizing canine T cell activation, expansion, and transduction

  2025cites this paper
• ICI-induced cardiovascular toxicity: mechanisms and immune reprogramming therapeutic strategies

  2025cites this paper
• Identification of Aerobic Salivary Microorganisms in Patients With Oral Squamous Cell Carcinoma Using MALDI‐TOF MS: Preliminary Findings From a Pilot Study

  2025cites this paper
• Ultrasmall lactoferrin/lipid multicompartmental nanomedicine-based reprogramming of glycolysis in triple-negative breast cancer via HDAC6/LDH axis enhances cancer immunotherapy

  2025cites this paper
• A Novel Prognostic Signature Integrating Immune and Glycolytic Pathways for Enhanced Prognosis and Immunotherapy Prediction in Hepatocellular Carcinoma

  2025cites this paper
• Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy

  2025cites this paper
• Obesity–cancer axis crosstalk: Molecular insights and therapeutic approaches

  2025cites this paper
• Age- and diet-instructed metabolic rewiring of the tumor-immune microenvironment.

  2025cites this paper
• Lactylation in Glioblastoma: A Novel Epigenetic Modifier Bridging Epigenetic Plasticity and Metabolic Reprogramming

  2025cites this paper
• Oxidant-Based Cytotoxic Agents During Aging: From Disturbed Energy Metabolism to Chronic Inflammation and Disease Progression

  2025cites this paper
• Tumor immune evasion: Systemic immunosuppressive networks beyond the local microenvironment

  2025cites this paper
• Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance

  2025cites this paper
• The regulatory role and mechanism of energy metabolism and immune response in head and neck cancer

  2025cites this paper
• The Role of Lactate and Lactylation in the Dysregulation of Immune Responses in Psoriasis

  2025cites this paper
• Role of the circular RNAs/microRNA/messenger RNA axis in renal cell carcinoma: From gene regulation to metabolism and immunity.

  2025cites this paper
• Hydrogel‐Based Tumor Tissue Microarchitecture Reshapes Dendritic Cell Metabolic Profile and Functions

  2025cites this paper
• The solid tumor microenvironment and related targeting strategies: a concise review

  2025cites this paper
• Reprogramming of Glucose Metabolism by Nanocarriers to Improve Cancer Immunotherapy: Recent Advances and Applications

  2025cites this paper
• Nanomedicine-driven tumor glucose metabolic reprogramming for enhanced cancer immunotherapy

  2025cites this paper
• PATHOLOGICAL PARAMETERS HELPFUL IN SCREENING AND STRATIFICATION OF COVID-19 PATIENTS

  2025cites this paper
• Metabolic Reprogramming of Glycolysis, Lipids, and Amino Acids in Tumors: Impact on CD8+ T Cell Function and Targeted Therapeutic Strategies

  2025cites this paper
• Metabolic modulation and immune checkpoint therapy: overcoming CD8 T cell exhaustion in the tumor microenvironment

  2025cites this paper
• Acidic urine as a prognostic factor after intravesical Bacillus Calmette–Guérin induction therapy for nonmuscle-invasive bladder cancer

  2025cites this paper
• Metal-phenolic networks reverse the immunosuppressive tumor microenvironment via dual metabolism regulation and immunogenic cell death.

  2025cites this paper
• Lactate metabolism and lactylation in breast cancer: mechanisms and implications

  2025cites this paper
• SLC16A3 (MCT4) expression in tumor immunity and Metabolism: Insights from pan-cancer analysis

  2025influential citation
• Comprehensive pan-cancer analysis identified SLC16A3 as a potential prognostic and diagnostic biomarker

  2025cites this paper
• Tumour and microenvironment crosstalk in NSCLC progression and response to therapy

  2025cites this paper
• Small-molecule inhibitors of 6-phosphofructo-1-kinase simultaneously suppress lactate and superoxide generation in cancer cells

  2025cites this paper
• Lactylation: From Homeostasis to Pathological Implications and Therapeutic Strategies

  2025cites this paper
• Tumor hypoxia shapes natural killer cell anticancer activities

  2025cites this paper
• Targeting metabolic reprogramming to overcome immune tolerance in melanoma immunotherapy

  2025cites this paper
• Serum proteomics reveals survival-associated biomarkers in pancreatic cancer patients treated with chemoimmunotherapy

  2025cites this paper